We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current GYRE market cap is 39.57M. The company's latest EPS is USD -36.7052 and P/E is -0.43.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 113.45M |
| Operating Income | -40.22M | -4.56M | -2.54M | -2.82M | -53.97M |
| Net Income | -40.45M | 260k | -2.47M | -1.58M | -89.15M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 20.95M | 7.34M | 794k | 113.45M |
| Operating Income | -57.28M | -57.37M | -87.89M | -65.8M | -63.89M |
| Net Income | -55.18M | -56.24M | -87.93M | -8.24M | -92.93M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 28.44M | 18.75M | 12.39M | 9.96M | 116.54M |
| Total Liabilities | 16.82M | 11.39M | 7.4M | 6.45M | 38.07M |
| Total Equity | -21.69M | -25.95M | -28.31M | 3.52M | 13.95M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 98.55M | 94.85M | 55.66M | 28.44M | 116.54M |
| Total Liabilities | 30.22M | 18.78M | 14.57M | 16.82M | 38.07M |
| Total Equity | 68.34M | 76.07M | 41.09M | -21.69M | 13.95M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -33.1M | -6.22M | -8.69M | -11.9M | 25.89M |
| Investing | 55.43M | 411k | 5.21M | 5.21M | -19.76M |
| Financing | -45.01M | -7.76M | -11.26M | -12.74M | 2.5M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -43.61M | -55.05M | -83.76M | -33.1M | 25.89M |
| Investing | 27.39M | 9.66M | 48.19M | 55.43M | -19.76M |
| Financing | 327k | 60.38M | 49.55M | -45.01M | 2.5M |
| Market Cap | 39.57M |
| Price to Earnings Ratio | -0.43 |
| Price to Sales Ratio | 0.35 |
| Price to Cash Ratio | 1.18 |
| Price to Book Ratio | 0.5 |
| Dividend Yield | - |
| Shares Outstanding | 2.53M |
| Average Volume (1 week) | 48.03k |
| Average Volume (1 Month) | 62.88k |
| 52 Week Change | 123.29% |
| 52 Week High | 30.40 |
| 52 Week Low | 5.88 |
| Spread (Intraday) | 8 (36.36%) |
| Company Name | Gyre Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.gyretx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
